Skip to content
Miyamoto Lab
Toggle menu
  • Home
  • Research
  • Team
  • News
  • Fun

Blood-Based Monitoring of Prostate Cancer

In the podcast Advances at Mass General Cancer Center, Dr. Miyamoto discusses our recent paper in Cancer Discovery on using a digital RNA analysis of CTCs to predict treatment outcomes in metastatic prostate cancer and early dissemination in localized prostate cancer.

Post navigation

Grant from Aid for Cancer Research
Welcome New Lab Members!

Recent Posts

  • Transdifferentiation and Recruitment in the Miyamoto Lab
  • Welcome New Lab Members!
  • Blood-Based Monitoring of Prostate Cancer
  • Grant from Aid for Cancer Research
  • Everyday Amazing Healthcare Professional

Archives

  • December 2021
  • January 2020
  • September 2018
  • May 2018
  • September 2017
  • June 2017

Contact the Principal Investigator

David Miyamoto, MD, PhD
Massachusetts General Hospital
149 13th Street, Rm 4406
Charlestown, MA  02129
email: dmiyamoto<at>mgh.harvard.edu

The Miyamoto Lab is dedicated to the pursuit of novel biomarkers to guide the personalized treatment of patients with prostate and bladder cancer. We are looking for talented and motivated students and postdoctoral researchers to join our team. Please email Dr. Miyamoto with your cover letter and CV.

https://youtu.be/ET6Roeqnqdw?list=FLpozl6WQx7BxAyq58zpvscA&t=151
© 2023 Miyamoto Lab. Proudly powered by Sydney